33. Pterygium - The GEC-ESTRO Handbook of Brachytherapy

Pterygium

8

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 01/03/2023

15. REFERENCES

22. Viani GA, De Fendi LI, Fonseca EC, Stefano EJ. Low or high fractionation dose β-radiotherapy for pterygium? A randomized clinical trial. Int J Radiat Oncol Biol Phys. 2012;82(2):e181-5. 23. Qin XJ, Chen HM, Guo L, Guo YY. Low-dose strontium-90 irradiation is effective in preventing the recurrence of pterygia: a ten-year study. PLoS One. 2012;7(8):e43500. 24. Yamada T, Mochizuki H, Ue T, Kiuchi Y, Takahashi Y, Oinaka M. Comparative study of different β-radiation doses for preventing pterygium recurrence. Int J Radiat Oncol Biol Phys. 2011;81(5):1394-8. 25. Viani GA, Stefano EJ, De Fendi LI, Fonseca EC. Long-term results and prognostic factors of fractionated strontium-90 eye applicator for pterygium. Int J Radiat Oncol Biol Phys. 2008;72(4):1174-9. 26. Isohashi F, Inoue T, Xing S, Eren CB, Ozeki S, Inoue T. Postoperative irradiation for pterygium: retrospective analysis of 1,253 patients from the Osaka University Hospital. Strahlenther Onkol. 2006;182(8):437-42. 27. Jürgenliemk-Schulz IM, Hartman LJ, Roesink JM, Tersteeg RJ, van Der Tweel I, Kal HB, Mourits MP, Wyrdeman HK. Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys. 2004;59(4):1138-47. 28. Monteiro-Grillo I, Gaspar L, Monteiro-Grillo M, Pires F, Ribeiro da Silva JM. Postoperative irradiation of primary or recurrent pterygium: results and sequelae. Int J Radiat Oncol Biol Phys. 2000;48(3):865-9. 29. Nishimura Y, Nakai A, Yoshimasu T, Yagyu Y, Nakamatsu K, Shindo H, Ishida O. Long-term results of fractionated strontium-90 radiation therapy for pterygia. Int J Radiat Oncol Biol Phys. 2000;46(1):137-41. 30. Fukushima S, Inoue T, Inoue T, Ozeki S. Postoperative irradiation of pterygium with 90Sr eye applicator. Int J Radiat Oncol Biol Phys. 1999;43(3):597-600. 31. de Keizer RJ. Pterygium excision with free conjunctival autograft (FCG) versus postoperative strontium 90 (90Sr) beta-irradiation. A prospective study. Int Ophthalmol. 1997-1998;21(6):335-41. 32. Paryani SB, Scott WP, Wells JW Jr, Johnson DW, Chobe RJ, Kuruvilla A, Schoeppel S, DeshmukhA. Management of pterygiumwith surgery and radiation therapy. The North Florida Pterygium Study Group. Int J Radiat Oncol Biol Phys. 1994;28(1):101-3. 33. Wesberry JM Jr, Wesberry JMSr. Optimal use of beta irradiation in the treatment of pterygia. South Med J. 1993;86(6):633-7. 34. Wilder RB, Buatti JM, Kittelson JM, ShimmDS, Harari PM, Rogoff EE, Cassady JR. Pterygium treated with excision and postoperative beta irradiation. Int J Radiat Oncol Biol Phys. 1992;23(3):533-7. 35. Beyer DC. Pterygia: single-fraction postoperative beta irradiation. Radiology. 1991;178(2):569-71. 36. Giannaccare G, Bernabei F, Angi M, Pellegrini M, Maestri A, Romano V, Scorcia V, Rothschild PR. Iatrogenic Ocular Surface Diseases Occurring during and/ or after Different Treatments for Ocular Tumours. Cancers. 2021;13(8):1933. 37. Nakamatsu K, Nishimura Y, Kanamori S, Koike R, Tachibana I, Nishikawa T, Shibata T. Randomized clinical trial of postoperative strontium-90therapy for pterygia: treatment using 30 Gy/3fractions vs. 40 Gy/4 fractions. Strahlenter Onkol 2011;187:401-405.

1. Fionda B, Lancellotta V, Casà C, Boldrini L, Marazzi F, Cellini F, Kovács G, Gambacorta MA, Tagliaferri L. Radiotherapy for benign disorders: current use in clinical practice. Eur Rev Med Pharmacol Sci. 2021;25(9):3440-3443. 2. Kirwan JF, Constable PH, Murdoch IE, Khaw PT. Beta irradiation: new uses for an old treatment: a review. Eye (Lond). 2003 Mar;17(2):207-15. 3. Rezvan F, Khabazkhoob M, Hooshmand E, Yekta A, Saatchi M, Hashemi H. Prevalence and risk factors of pterygium: a systematic review andmeta-analysis. Surv Ophthalmol. 2018;63(5):719-735. 4. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review andmeta-analysis. BMJ Open. 201;3(11):e003787. 5. Rigendinger F, AebersoldDM, Cvejic Z, Pajic B. Changes of Corneal Biomechanical Properties upon Exclusive Ytt-/Sr-90 Irradiation of Pterygium. Sensors (Basel). 2021;21(3):975. 6. Nuzzi R, Tridico F. How to minimize pterygium recurrence rates: clinical perspectives. Clin Ophthalmol. 2018;12:2347-2362. 7. Otlu B, Emre S, Turkcuoglu P, Doganay S, Durmaz R. Investigation of human papillomavirus and Epstein-Barr virus DNAs in pterygium tissue. Eur J Ophthalmol. 2009;19(2):175-9. 8. Shahraki T, Arabi A, Feizi S. Pterygium: an update on pathophysiology, clinical features, and management. Ther Adv Ophthalmol. 2021 May 31;doi: 10.1177/25158414211020152. 9. Sánchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol. 1998;82(6):661-5. 10. Clearfield E, MuthappanV,Wang X, Kuo IC. Conjunctival autograft for pterygium. Cochrane Database Syst Rev. 2016;2:CD011349. 11. Zeng W, Liu Z, Dai H, Yan M, Luo H, Ke M, Cai X. Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis. BMC Ophthalmol. 2017 Nov 25;17(1):211. 12. Fonseca EC, Rocha EM, Arruda GV. Comparison among adjuvant treatments for primary pterygium: a networkmeta-analysis. Br J Ophthalmol. 2018;102(6):748- 756. 13. Chu WK, Choi HL, Bhat AK, Jhanji V. Pterygium: new insights. Eye (Lond). 2020;34(6):1047-1050. 14. Pajic B, Pallas A, Aebersold D, Gruber G, Greiner RH. Prospective study on exclusive, nonsurgical strontium-/yttrium-90 irradiation of pterygia. Strahlenther Onkol. 2004;180(8):510-6. 15. Cohen VM, Papastefanou VP, Liu S, Stoker I, Hungerford JL. The use of strontium-90 Beta radiotherapy as adjuvant treatment for conjunctival melanoma. Journal of Oncology. 2013: doi.org/10.1155/2013/349162. 16. Sou-Tung Chiu-Tsao, Ph.D. PTERYGIUMBRACHYTHERAPY PHYSICS Beth Israel Medical Center & St. Luke’s - Roosevelt Hospital Center New York, NY ABS/AAPM Summer School, Seattle, July 21, 2005 17. Marr BP, Abramson DH, Cohen GN, Williamson MJ, McCormick B, Barker CA. Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity. JAMA Ophthalmol. 2015;133(3):283-9. 18. Nazempoor A, Aghamiri S, Poorbaygi H, Eidi T, Saghamanesh S, Javanshir M. Dose Assessment of Phosphorus-32 (32P) for the Treatment of Recurrent Pterygium. Iranian Journal of Medical Physics, 2014; 11(4): 328-333. 19. Rosenthal JW. Beta-radiation therapy of pterygium. AMA Arch Ophthalmol. 1953;49(1):17-23. 20. Brenner DJ, Merriam GR. Postoperative irradiation for pterygium: guidelines for optimal treatment. Int J Radiat Oncol Biol Phys. 1994;30(3):721–725. 21. Ali AM, Thariat J, Bensadoun RJ, Thyss A, Rostom Y, El-Haddad S, Gérard JP. The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions. Cancer Radiother. 2011;15(2):140-7.